Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cross-sectional Study of Patients With Immune Thrombocytopenic Purpura and Caregivers to Estimate the Proportion Who Administer Romiplostim Correctly After Receipt of Home Administration Training Materials

NCT02085993 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

NCT NCT02085993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02085993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cross-sectional Study of Patients With Immune Thrombocytopenic Purpura and Caregivers to Estimate the Proportion Who Administer Romiplostim Correctly After Receipt of Home Administration Training Materials
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
July 31, 2014
Completion date
November 30, 2015
Enrollment
41 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenic purpura